Form 4 for INCY Incyte

Accepted 2025-06-30 00:00:00 ET · period of report 2025-06-26 · accession 0001628280-25-033513 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2025-06-30	2025-06-26	INCY	Hoppenot Herve	Special Advisor to the CEO, Dir	A - Grant	$0.00	+6,016	569.6K	+1%	$0
DM	2025-06-30	2025-06-26	INCY	Hoppenot Herve	Special Advisor to the CEO, Dir	A - Grant	$0.00	+36.5K	18.4K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2025-06-26	A	A	6,016	$0.00	569,589	D	—	—	(F1) Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis. (F2) Including the June 26, 2025 grant, this includes an aggregate of 187,611 shares of common stock issuable pursuant to previously reported RSUs and earned performance shares that have not vested.
2	Derivative	Performance Shares	2025-06-26	A	A	18,050	$0.00	18,050	D	— · — to 2028-06-26	18,050 Common Stock	(F4) Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ('TSR') over a three-year performance period beginning on January 1, 2025 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date.
3	Derivative	Employee Stock Option (right to buy)	2025-06-26	A	A	18,438	$0.00	18,438	D	$70.81 · — to 2035-06-25	18,438 Common Stock	(F3) The June 26, 2025 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.